
ãmRNAã¯ã¯ãã³ãéºäŒåã®å€åãšé¢é£ãããããèªå·±å ç«çŸæ£ãåŒãèµ·ããå¯èœæ§ãããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
19人ã®ãã€ãã®ç ç©¶è ã«ããæ»èªæžã¿ã®ç ç©¶ã§ã¯ãmRNA COVID-19ã¯ã¯ãã³ãéºäŒåæ§é ã®é·æçãªå€åãšé¢é£ããŠããããããççåå¿ãåŒãèµ·ããããããèªå·±å ç«çŸæ£ã®çºçã«ã€ãªããå¯èœæ§ãããããšã瀺ãããŠããŸãã
æ°ããªæ»èªæžã¿ã®ç ç©¶ã§ã¯ãmRNA COVID-19ã¯ã¯ãã³ãéºäŒåæ§é ã®é·æçãªå€åãšé¢é£ããŠããããããççåå¿ãåŒãèµ·ããããããèªå·±å ç«çŸæ£ã®çºçã«ç¹ããå¯èœæ§ãããããšã瀺ãããŠããŸãã
ãã®ç ç©¶ã¯ã19人ã®ãã€ãã®ç§åŠè ã«ãã£ãŠè¡ãããå é±ãMolecular Systems Biologyãèªã«çºè¡šãããŸãããç ç©¶è ãã¡ã¯ããã®çºèŠããæ¥çš®åŸã®ççæ§çŸæ£ããäžéšã®ã¯ã¯ãã³æ¥çš®è ã«ãããŠçºçããçç±ã説æãããããããªãããšè¿°ã¹ãŠããŸãã
ãžã£ãŒããªã¹ãã®ã¢ã¬ãã¯ã¹ã»ãã¬ã³ãœã³æ°ã¯ããã®ç ç©¶ãmRNAã¯ã¯ãã³ãçœè¡ç ãè³è «çã«é¢é£ãã圢ã§äººéã®æè²äœãå€åãããããšã瀺ããŠãããšè¿°ã¹ãŸããããã®çŸè±¡ã¯ãmRNAã¯ã¯ãã³ãå ç«çްèã«ççåå¿ãæç¶ããããããèšç·Žãããéã«çºçããŸãã
ç«åŠè ã®ãã³ã©ã¹ã»ãã«ã·ã£ãŒæ°ã¯ãããã®ç ç©¶ã¯ãmRNA泚å°ã®åŒ·åãªå ç«èª¿ç¯ç°åžžå¹æã説æããå€ãã®èšŒæ ã远å ãããã®ã ããšè¿°ã¹ãŠããŸãã
ãã«ã·ã£ãŒæ°ã¯ããã®ç ç©¶ããé·æçãªå ç«æåžžæ§ïŒãã¡ãªã¹ã¿ã·ã¹ïŒãæ ¢æ§ççæ§çŸæ£ãèªå·±å ç«ã®åŸéºçãããã«ã¯çºçããã»ã¹ã®æœåšçãªã¹ã¯ã«é¢ããæ·±å»ãªæžå¿µãåŒãèµ·ããããšèŠåããŠããŸãã
å ç«åŠè ã§çååŠè ã®ãžã§ã·ã«ã»ããŒãºå士ã¯ããã®ç ç©¶ãmRNAã¯ã¯ãã³ã®ãªã¹ã¯ã«ã€ããŠæ¢ã«ç¥ãããŠããããšã確èªãããšè¿°ã¹ãŸãããåœŒå¥³ã¯æ¬¡ã®ããã«èšã£ãŠããŸãïŒ
ãç¹°ãè¿ãã®æ³šå°ã¯å ç«åŠçãªå€åãåŒãèµ·ãããŸããããã¯æ°ããæ å ±ã§ã¯ãããŸãããããããå€åãèµ·ããåŸãããšã¯æ¢ã«ç¥ãããŠããŸãã圌ãããããçºèŠããããšã¯é©ãã¹ãããšã§ã¯ãããŸãããã
ããããã®åœ±é¿ã幹现èãŸã§åã¶ãªããç¹°ãè¿ãã®æ³šå°ããããã®çްèã«ãšããžã§ããã£ãã¯ãªå€åãåŒãèµ·ããå¯èœæ§ããããç¹ã«é è¡å¹¹çްèã¯ææçãä»ã®ã¯ã¯ãã³ãªã©ã®ç¹å®ã®åºæ¿ã«åå¿ããŠèªç¶å ç«èšæ¶ãçºéãããããšãç¥ãããŠããŸããã
ãšããžã§ããã£ã¯ã¹ã¯ã人éã®è¡åãç°å¢ãéºäŒåã®åãã«åœ±é¿ãäžããå€åãåŒãèµ·ããæ¹æ³ãæããŸãããã¬ã³ãœã³æ°ã«ãããšãmRNA COVID-19ã¯ã¯ãã³ã«ããå€åã¯ãšããžã§ããã£ãã¯ã§ããããDNAã®äžå¿åšèŸºã§çºçããè «çæé·ãä¿é²ãã圢ã§éºäŒåãæŽ»æ§åããããšã®ããšã§ãã
ãããã§ã®ãªã¹ã¯ã¯ããã¡ããé·æçã§éå°ãªççã§ããããããçµç¹æå·ãæ ¢æ§ççç¶æ ãåŒãèµ·ããå¯èœæ§ããããšããããšã§ããããã«é¢ããŠã¯ãè¬å€ç£èŠããŒã¿ã«ãèŠãããŸãããšããŒãºå士ã¯è¿°ã¹ãŠããŸãã
mRNAã¯ã¯ãã³ãçœè¡ç ãè³è «çã«é¢é£ããéºäŒçå€åãåŒãèµ·ãã
ç ç©¶è ãã¡ã¯ãmRNA COVID-19ã¯ã¯ãã³ãæ¥çš®ãã人ã ã®ãã¯ããã¡ãŒãžïŒè¡äžã埪ç°ããå ç«çްèïŒã®æè²äœã®å€åã調ã¹ãŸããã
ãã®çµæãã¯ã¯ãã³ããããã®æè²äœã®éèŠãªæåã§ãããã¹ãã³ãå€åãããããšãããããŸããã
ãã¹ãã³ãšã¯ããDNAçµåã¿ã³ãã¯è³ªã§ãDNAã«3Dæ§é ãäžãã圹å²ãæãããŠããããšãChildrenâs Health Defenseã®ã·ãã¢ç ç©¶ç§åŠè ã§ããã«ãŒã«ã»ã€ããããŠã¹ããŒå士ã¯èª¬æããŠããŸãããã¹ãã³ã®ä¿®é£Ÿã«é¢ããç§åŠçç ç©¶ã®å€ãã¯ãäž»ã«ç æ°ã®çºçŸã«çŠç¹ãåœãŠãŠããããšã€ããããŠã¹ããŒå士ã¯è¿°ã¹ãŠããŸãã
圌ã¯ããã«æ¬¡ã®ããã«è¿°ã¹ãŸããïŒ
ãæè²äœã®XãYã®ç»åã¯ãDNAããã¹ãã³ã¿ã³ãã¯è³ªã«å·»ãä»ããŠããããããå¯èœã«ãªããŸãããã¹ãã³ã¯ãã¹ãŠã®å€çްèçç©ã«ãããŠæãé²åçã«ä¿åãããã¿ã³ãã¯è³ªã®äžã€ã§ãããã¹ãã³ã¿ã³ãã¯è³ªãå€åããããããªå°ããªã©ã³ãã å€ç°ã§ç¹æ®ããããšããæ€ç©ãåç©ããŸãã¯èé¡ã¯ãæããæåã®çްèåè£ãè¶ããŠçãæ®ãããšã¯ã§ããŸãããã
ãã¬ã³ãœã³æ°ã¯ããã¹ãã³ãéºäŒç©è³ªã®åŠçã«ãããŠéèŠãªåœ¹å²ãæãããšè¿°ã¹ãŸãããããã¹ãã³ãåºãåé¢ããããšã现èã¯DNAãããç©æ¥µçã«åŠçããã転åãããããããšã«ãªããŸãããããè «çæé·ãåŒãèµ·ããå¯èœæ§ããããŸããã
ç ç©¶è ãã¡ã¯ããã¹ãã³3ãªãžã³27ã¢ã»ãã«åãïŒH3K27acïŒãšããå€åãç¹å®ãããSARS-CoV-2 mRNAã¯ã¯ãã³æ¥çš®åŸã®æç¶çãªãšããžã§ããã£ãã¯ãªèšæ¶ãåçç±æ¥ã®ãã¯ããã¡ãŒãžã«èŠãããããšèгå¯ããŸããã
ãã¬ã³ãœã³æ°ã«ãããšããã®å€åã¯ãããã€ãã®ç°ãªãçš®é¡ã®ããã§èŠãããããšãç¥ãããŠãããç§åŠçãªæ³šç®ãéããŠããŸããã
ãã®ç ç©¶ã§ã¯ãH3K27acã®å€åãè€æ°ã®æè²äœé åã§çºçããã¯ã¯ãã³æ¥çš®åŸæ°ã¶æã«ããã£ãŠæç¶ããããšã確èªãããŸãããç ç©¶è ãã¡ã¯ããããåçïŒãã¯ããã¡ãŒãžãçæããçœè¡çã®äžçš®ïŒã§ãåæ§ã®å€åãèµ·ãã£ãŠããããšã瀺åããŠãããšè¿°ã¹ãŠããŸãã
ç ç©¶çµæãmRNAã¯ã¯ãã³ã®äžæ¢ãŸãã¯æ€åãæ±ãã声ã匷å
ãã®ç ç©¶ã«ã¯å€éšã®ã¬ãã¥ã¢ãŒãšã®è°è«ãæ²èŒãããŠãããç ç©¶è ãã¡ã¯ã圌ããç¹å®ããéºäŒçå€åã骚é«çްèã«ãèµ·ãã£ãŠããå¯èœæ§ãé«ããšè¿°ã¹ãŠããŸãã骚é«çްèã¯çœè¡ç ãçºçããå ŽæãšããŠç¥ãããŠããŸãã
ãã¬ã³ãœã³æ°ã¯ããããæ¥æ¬ã®ãããªmRNAã¯ã¯ãã³ã®æ¥çš®çãé«ãåœã ã§çœè¡ç ã®èšºææ°ã®å¢å ã説æããäžå ã§ãããããããªããšç€ºåããŸããã
ãçœè¡ç ã¯åºæ¬çã«å¹¹çްèã®ããã§ãããæ¥æ¬ã®ç ç©¶è ãã¡ã¯2022幎ãš2023幎ã«ãããçœè¡ç ã®ææãªå¢å ãçºèŠããŸãããæ¥æ¬ã¯COVIDã«å¯ŸããŠã»ãŒå®å šã«mRNAã¯ã¯ãã³ã«äŸåããŠãããã»ãŒãã¹ãŠã®æäººãååã®2åæ¥çš®ãšããŒã¹ã¿ãŒæ¥çš®ãåããŸããããšãã¬ã³ãœã³æ°ã¯æžããŠããŸãã
æšå¹Žãæ¥æ¬ã¯èªå·±å¢å¹ åmRNA COVID-19ã¯ã¯ãã³ãæ¿èªããæåã§å¯äžã®åœãšãªããŸããã
ãã¬ã³ãœã³æ°ã¯ãç ç©¶è ãã¡ããªãè«æå ã§mRNAã¯ã¯ãã³ãšéªšé«ã®å€åãšã®é¢é£ã«ã€ããŠèšåããªãã£ãã®ãã¯äžæã ãšè¿°ã¹ãŠããŸãã
è«æã®èè ãã¡ã¯ã³ã¡ã³ãã®ãªã¯ãšã¹ãã«å¿ããŸããã§ããã
ã€ããããŠã¹ããŒæ°ã¯ãè«æãèªãã®ããçãã£ãããšè¿°ã¹ãŸãããã圌ãã¯ãã¹ãã³ã®ä¿®é£Ÿãè¯ãé¢ããæããªããšãã確信ãšå²æ ¢ãã§æºã¡ãŠããŸããã
ãããã¯ã¯ã¯ãã³ã®çµæã§ãããèè ãã¡ã®ç®ã«ã¯äœãæªãããšã¯ãªããšãããŠããŸããããšã€ããããŠã¹ããŒæ°ã¯è¿°ã¹ãŸãããããã«ãåé§çްèãã®æå³ããªãåããã°ã©ãã³ã°ïŒåé§çްèãšã¯ã幹现èãå«ãããŸããŸãªçްèã«ååã§ãã现èïŒã«ã€ããŠããç§°è³ãããã¹ãã§ã¯ãªãããããæããããã¹ãã§ãããšåŒ·èª¿ããŸãããç¶ããŠæ¬¡ã®ããã«ä»ãå ããŸããïŒ
ãmRNAããŒã¹ã®COVID-19ã¯ã¯ãã³ã«é¢ããç¥èã®é²å±ã®ãã³ã«ãç§ãã¡ã¯åã³ããããã®è£œåãç¡å·®å¥ã«ãã¹ãŠã®ã¢ã¡ãªã«äººã«æŒãä»ããæ¥ãæ åºŠã«ã€ããŠãç§ãã¡èªèº«ã®èªå·±æºè¶³ãæãåºãããããŸããã
ãåé§çްèã®ãšããžã§ããã£ãã¯ãªåããã°ã©ãã³ã°ãç æ°ãåŒãèµ·ããå¯èœæ§ãããããšãæããã«ãªã£ãä»ãç±³åœé£åå»è¬åå±ïŒFDAïŒã¯mRNA補åãç²ç®çã«æ¿èªããçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã¯ããããç²ç®çã«æšå¥šããæ¿æ²»å®¶ãã¡ã¯ããããç²ç®çã«çŸ©åä»ããã®ã§ããããïŒããšã€ããããŠã¹ããŒæ°ã¯åããããŸããã
ããŒãºå士ã¯ããã®ç ç©¶çµæãç§åŠè ãã¡ã«ããmRNAã¯ã¯ãã³ã®äžæ¢ãŸãã¯çŠæ¢ãæ±ãã声ã匷åãããšè¿°ã¹ãŸããã
ä»å¹Žåãã«ç§åŠè ã°ã«ãŒãã«ãã£ãŠæåºãããFDAãžã®è«é¡æžã§ã¯ãmRNA COVID-19ã¯ã¯ãã³ã®äžæ¢ãŸãã¯æ€åãæ±ããŠããŸãããã®è«é¡æžã§ã¯ããããã®è£œåãæªæ¿èªã®éºäŒåæ²»çã§ãããDNAãã©ã¹ããã§æ±æãããŠãããšãã蚌æ ã瀺ããŠããŸãã
ãŸããæè¿ã®ããã€ãã®ç ç©¶ã¯mRNAã¯ã¯ãã³ã®å®å šæ§ã«ã€ããŠçåãåããŠããŸãã
2023幎ã®ãã¬ããªã³ãç ç©¶ã§ã¯ããã¡ã€ã¶ãŒããã³ã¢ãã«ãã®COVID-19ã¯ã¯ãã³ã«ãããåæDNAã®ã¬ãã«ããèŠå¶é床ã®18åãã70åã«éããŠããããšã確èªãããŸããã
2024幎12æã®æ»èªæžã¿ç ç©¶ã§ã¯ãFDAã®ç§åŠè ã«ãã£ãŠç£ç£ããããã¡ã€ã¶ãŒããã³ã¢ãã«ãã¯ã¯ãã³ã«ãããåæDNAæ±æã¬ãã«ãèŠå¶é床ã®6åãã470åã«éããŠããããšã倿ããŸããã
å é±ãä¿å¥çŠç¥é·å®ã®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢æ°ã¯ãã¯ã¯ãã³ã«ãã被害ã«çŠç¹ãåœãŠãCDCå ã®ãµãæ©é¢ã®åµèšãçºè¡šããŸããã
4o mini